Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.630
-0.300 (-6.09%)
Jun 12, 2025, 4:00 PM - Market closed
Y-mAbs Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 60.31 | 67.23 | 78.64 | 105.76 | 181.56 | 114.63 | Upgrade
|
| Cash & Short-Term Investments | 60.31 | 67.23 | 78.64 | 105.76 | 181.56 | 114.63 | Upgrade
|
| Cash Growth | -20.38% | -14.50% | -25.65% | -41.75% | 58.39% | -44.66% | Upgrade
|
| Receivables | 17.74 | 19.69 | 22.45 | 12.53 | 7.71 | - | Upgrade
|
| Inventory | 8 | 7.21 | 5.07 | 6.7 | 5.51 | - | Upgrade
|
| Other Current Assets | 4.4 | 4.37 | 4.96 | 5.45 | 7.47 | 7.73 | Upgrade
|
| Total Current Assets | 90.45 | 98.51 | 111.11 | 130.45 | 202.26 | 122.36 | Upgrade
|
| Property, Plant & Equipment | 0.76 | 0.86 | 1.64 | 2.34 | 5.69 | 6.39 | Upgrade
|
| Other Intangible Assets | 2.21 | 2.28 | 2.63 | 2.99 | 1.66 | - | Upgrade
|
| Other Long-Term Assets | 19.19 | 18.26 | 12.49 | 5.68 | 3.17 | 3.29 | Upgrade
|
| Total Assets | 112.61 | 119.9 | 127.87 | 141.46 | 212.78 | 132.05 | Upgrade
|
| Accounts Payable | 4.63 | 6.66 | 6.06 | 14.18 | 13.55 | 9.37 | Upgrade
|
| Accrued Expenses | 7.53 | 8.18 | 7.41 | 6.77 | 6.84 | 4.59 | Upgrade
|
| Current Portion of Leases | 0.46 | 0.63 | 0.9 | 0.87 | 1.78 | 1.97 | Upgrade
|
| Other Current Liabilities | 6.35 | 8.22 | 5.76 | 6.48 | 5.71 | 3.61 | Upgrade
|
| Total Current Liabilities | 18.96 | 23.7 | 20.13 | 28.28 | 27.88 | 19.54 | Upgrade
|
| Long-Term Leases | 0.15 | 0.19 | 0.52 | 0.9 | 1.85 | 2.01 | Upgrade
|
| Other Long-Term Liabilities | 4.05 | 4.01 | 6.24 | 3.05 | 2.95 | 4.66 | Upgrade
|
| Total Liabilities | 23.16 | 27.9 | 26.88 | 32.24 | 32.68 | 26.21 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 580.38 | 576.87 | 558 | 543.93 | 519.21 | 391.56 | Upgrade
|
| Retained Earnings | -492.33 | -487.14 | -457.47 | -436.04 | -340.48 | -285.2 | Upgrade
|
| Comprehensive Income & Other | 1.4 | 2.26 | 0.45 | 1.33 | 1.37 | -0.53 | Upgrade
|
| Shareholders' Equity | 89.46 | 92 | 100.99 | 109.22 | 180.11 | 105.84 | Upgrade
|
| Total Liabilities & Equity | 112.61 | 119.9 | 127.87 | 141.46 | 212.78 | 132.05 | Upgrade
|
| Total Debt | 0.6 | 0.82 | 1.42 | 1.77 | 3.63 | 3.98 | Upgrade
|
| Net Cash (Debt) | 59.71 | 66.41 | 77.22 | 104 | 177.93 | 110.66 | Upgrade
|
| Net Cash Growth | -19.93% | -13.99% | -25.75% | -41.55% | 60.80% | -46.00% | Upgrade
|
| Net Cash Per Share | 1.34 | 1.50 | 1.77 | 2.38 | 4.12 | 2.76 | Upgrade
|
| Filing Date Shares Outstanding | 45.28 | 45.22 | 43.78 | 43.68 | 43.71 | 43.53 | Upgrade
|
| Total Common Shares Outstanding | 45.25 | 44.99 | 43.67 | 43.67 | 43.69 | 40.69 | Upgrade
|
| Working Capital | 71.49 | 74.81 | 90.98 | 102.16 | 174.39 | 102.83 | Upgrade
|
| Book Value Per Share | 1.98 | 2.05 | 2.31 | 2.50 | 4.12 | 2.60 | Upgrade
|
| Tangible Book Value | 87.24 | 89.73 | 98.35 | 106.24 | 178.44 | 105.84 | Upgrade
|
| Tangible Book Value Per Share | 1.93 | 1.99 | 2.25 | 2.43 | 4.08 | 2.60 | Upgrade
|
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.